SEER

Seer Inc

SEER, USA

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

https://seer.bio

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SEER
stock
SEER

Aug Decliners: What insider trading reveals about SEER stock - Portfolio Performance Summary & Risk Adjusted Buy and Sell Alerts moha.gov.vn

Read more →
SEER
stock
SEER

Leidos (NYSE: LDOS) integrates CargoSeer AI into Mezzo platform for border security Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$3

Analyst Picks

Strong Buy

1

Buy

0

Hold

2

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.37

Low 1

High 3

Return on Equity (ROE)

-

Very Low

-6.71 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-5.91 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-190.46 %

Low 5%

High 15%

Debt to Equity

-

Very High

0.14

Low 1

High 0.3

Investors

* Institutions hold a combined 48.27% of the total shares of Seer Inc

1.

SoftBank Group Corp

(9.1151%)

since

2025/06/30

2.

Siren, L.L.C.

(7.0998%)

since

2025/06/30

3.

Vanguard Group Inc

(3.9096%)

since

2025/06/30

4.

BlackRock Inc

(3.3269%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(2.7476%)

since

2025/07/31

6.

TANG CAPITAL MANAGEMENT LLC

(2.3863%)

since

2025/06/30

7.

Renaissance Technologies Corp

(1.9839%)

since

2025/06/30

8.

Bridgeway Capital Management, LLC

(1.4864%)

since

2025/06/30

9.

AJU IB Investment Co Ltd

(1.449%)

since

2025/06/30

10.

Bridgeway Ultra-Small Company

(1.2567%)

since

2025/06/30

11.

FMR Inc

(1.2498%)

since

2025/06/30

12.

D. E. Shaw & Co LP

(1.2427%)

since

2025/06/30

13.

Fidelity OTC

(1.0339%)

since

2025/07/31

14.

Two Sigma Advisers, LLC

(0.9226%)

since

2025/06/30

15.

Geode Capital Management, LLC

(0.9047%)

since

2025/06/30

16.

Peapod Lane Capital LLC

(0.7646%)

since

2025/06/30

17.

Vanguard Institutional Extnd Mkt Idx Tr

(0.7156%)

since

2025/07/31

18.

1888 Investments, LLC

(0.6375%)

since

2025/06/30

19.

Millennium Management LLC

(0.6069%)

since

2025/06/30

20.

Jacobs Levy Equity Management, Inc.

(0.5811%)

since

2025/06/30

21.

BlackRock Advantage Small Cap Core Instl

(0.5451%)

since

2025/07/31

22.

Two Sigma Investments LLC

(0.5102%)

since

2025/06/30

23.

Morgan Stanley - Brokerage Accounts

(0.4945%)

since

2025/06/30

24.

Berkshire Asset Management Inc

(0.4881%)

since

2025/06/30

25.

Royal Bank of Canada

(0.4718%)

since

2025/06/30

26.

Fidelity Extended Market Index

(0.3758%)

since

2025/07/31

27.

Invesco RAFI US 1500 Small-Mid ETF

(0.2287%)

since

2025/08/29

28.

Bridgeway Ultra-Small Company Market

(0.2071%)

since

2025/06/30

29.

Blackrock Russell 2000 Alpha Tilts Fd A

(0.2016%)

since

2025/06/30

30.

iShares Micro-Cap ETF

(0.1971%)

since

2025/08/31

31.

Fidelity Nasdaq Composite Index

(0.1513%)

since

2025/07/31

32.

Fidelity Total Market Index

(0.1457%)

since

2025/07/31

33.

Extended Equity Market Fund K

(0.1422%)

since

2025/06/30

34.

Fidelity OTC Commingled Pool Class D

(0.1416%)

since

2025/07/31

35.

Avantis US Small Cap Equity ETF

(0.1092%)

since

2025/08/30

36.

Fidelity Series Total Market Index

(0.0983%)

since

2025/07/31

37.

Northern Trust Extended Eq Market Idx

(0.0895%)

since

2025/06/30

38.

NT Ext Equity Mkt Idx Fd - L

(0.0895%)

since

2025/06/30

39.

Spartan Extended Market Index Pool F

(0.089%)

since

2025/07/31

40.

Goldman Sachs Absolute Ret Trckr Instl

(0.0729%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.31

Latest Release

Date

2025-09-30

EPS Actual

-0.32

EPS Estimate

-0.31

EPS Difference

-0.01

Surprise Percent

-3.2258%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(2.5)
Net Net
Possible Net-Net(6)
Quality
Low Quality Business(3)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.